Pharmaceutical group · India
Zydus Lifesciences
A group of 14 companies with 237 medicines in 4 countries.
Group structure
14 companies in 7 countries
Loading your page…
Loading your page…
Pharmaceutical group · India
A group of 14 companies with 237 medicines in 4 countries.
14 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 237
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACECLOFENACO | Aceclofenac | Brazil | Authorised | 2017 |
| ACYCLOVIR200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG | 800MG · Tablet | Aciclovir | United States | Marketed | 1997 |
| ACYCLOVIR SODIUM1gm base/vial | 25mg base/ml | 500mg base/vial | 50mg base/ml · Injectable | Aciclovir | United States | Marketed | 1997 |
| ALBENDAZOLE200mg · Tablet | Albendazole | United States | Marketed | 2018 |
| ALPRAZOLAM | Alprazolam | Brazil | Authorised | 2009 |
| Alzyd | Rasagiline | Brazil | Authorised | 2024 |
| AMANTADINE HYDROCHLORIDE68.5mg base · Capsule, extended release | Amantadine | United States | Not marketed | 2024 |
| AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE10mg; 20mg | 10mg; 40mg | 2.5mg; 10mg | 5mg; 10mg | 5mg; 20mg · Capsule | Amlodipine, Benazepril | United States | Marketed | 2011 |
| AMMONIUM LACTATE12% base · Lotion | Ammonium | United States | Marketed | 2002 |
| ANDHORA | Trazodone | Brazil | Authorised | 2020 |
| APALUTAMIDE60mg · Tablet | Apalutamide | United States | Marketed | 2025 |
| apixabana | Apixaban | Brazil | Authorised | 2020 |
| ARIPIPRAZOL | Aripiprazole | Brazil | Authorised | 2016 |
| ASPIRIN AND DIPYRIDAMOLE25mg; 200mg · Capsule, extended release | Acetylsalicylic acid, Dipyridamole | United States | Marketed | 2009 |
| ATENOLOL AND CHLORTHALIDONE100mg; 25mg | 50mg; 25mg · Tablet | Atenolol, Chlorthalidone | United States | Marketed | 1990 |
| axetilcefuroxima | Axetilcefuroxima | Brazil | Authorised | 2025 |
| benzoato de rizatriptana | Rizatriptan | Brazil | Authorised | 2023 |
| BROMOCRIPTINE MESYLATE5mg base · Capsule | Bromocriptine | United States | Marketed | 1998 |
| CANDESARTAN CILEXETIL16mg | 32mg | 4mg | 8mg · Tablet | Candesartan cilexetil | United States | Marketed | 2013 |
| CARBIDOPA25mg · Tablet | Carbidopa | United States | Marketed | 2014 |
| carbidopa + levodopa | Carbidopa, Levodopa | Brazil | Authorised | 2023 |
| carvedilol | Carvedilol | Brazil | Authorised | 2019 |
| celecoxibe | Celecoxib | Brazil | Authorised | 2019 |
| CITALOPRAM | Citalopram | Brazil | Authorised | 2006 |
| citrato de sildenafila | Sildenafil | Brazil | Authorised | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 136 | 101 | 35 | CompaniesAll medicines |
| United States | 79 | 65 | 14 | CompaniesAll medicines |
| Canada | 14 | 14 | 0 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
Also in the registers of France, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions